Patent · US Active

Nucleic acids encoding respiratory syncytial virus subgroup B strain 9320

US8163530B2 · kind B2 · utility

7Cited by
5References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 23, 2009
Grant dateApr 24, 2012
Priority date—
Expiry dateJul 23, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/18522
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The complete polynucleotide sequence of the human respiratory syncytial virus subgroup B strain 9320 genome is provided. Proteins encoded by this polynucleotide sequence are also provided. Isolated or recombinant RSV (e.g., attenuated recombinant RSV), nucleic acids, and polypeptides, e.g., comprising mutations in the attachment protein G, are also provided, as are immunogenic compositions comprising such isolated or recombinant RSV, nucleic acids, and polypeptides. Related methods are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.